Lawrence Kenyon
CFO
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Outlook Therapeutics, Inc. (OTLK) | CEO | $475,000 | $476,170 |
| 2024 | Outlook Therapeutics, Inc. (OTLK) | CEO | $475,000 | $634,597 |
| 2021 | Outlook Therapeutics, Inc. (OTLK) | CFO | $425,000 | $2,669,214 |
| 2020 | Outlook Therapeutics, Inc. (OTLK) | CFO | $425,000 | $1,184,334 |
| 2019 | Outlook Therapeutics, Inc. (OTLK) | CEO | $425,000 | $1,863,901 |
| 2018 | Outlook Therapeutics, Inc. (OTLK) | CEO | $371,635 | $716,132 |
Executive changes
Earnings-call appearances
-
Outlook Therapeutics, Inc. Q3 FY2024 Earnings Call2024-08-14
Outlook Therapeutics, Inc. (OTLK)
-
Outlook Therapeutics, Inc. Q2 FY2024 Earnings Call2024-05-16
Outlook Therapeutics, Inc. (OTLK)